Clinical Trial Update: Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic interaction study in healthy subjects to evaluate how BMS-791325 affects midazolam exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BMS-791325
• Midazolam (Midazolam)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED